Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Two Business Units with New Management

Published: Wednesday, November 14, 2012
Last Updated: Wednesday, November 14, 2012
Bookmark and Share
Leadership change at Bosch Packaging Technology.

Uwe Harbauer takes on his new position as Senior Vice President Business Unit Pharma at Bosch Packaging Technology in Crailsheim, Germany, on January 1, 2013. He replaces Wolfgang Szczerba, who retires after 34 years at Bosch. Harbauer himself will be succeeded as Senior Vice President Packaging Services in Beringen, Switzerland, by Walter Häcki (48). Häcki already moved to his new position on November 1, 2012.

Mechanical engineer Szczerba, who will celebrate his 60th birthday in January, started his career as development engineer in the Packaging Technology division back in 1981. In 2000, he became technical plant manager of the Crailsheim site, and since 2002 he has been responsible for Bosch Packaging Technology’s Pharma business unit.

Harbauer with long-term sales and service experience
His successor Uwe Harbauer also graduated in mechanical engineering and started working for Bosch Packaging Technology in 2000. He draws on many years of experience as head of sales of the Pharma business unit, and as senior vice president in charge of customer service. Most recently he held the position of Senior Vice President Business Unit Packaging Services in Beringen, Switzerland.

Walter Häcki takes over Packaging Services business unit
Walter Häcki (48) already took on his new position as Senior Vice President Business Unit Packaging Services on November 1, 2012. Swissborn Häcki graduated as trade merchant and, in 2000, started working for Sigpack Systems, which has been part of Bosch since 2004. He was headof supply chain management in Beringen, and member of the executive management in Budapest, Hungary. From 2008 to 2012, Häcki was responsible for Bosch Packaging Technology’s Chinese locations in Hangzhou (Zhejiang province) and Chengdu (Sichuan province). Chee Kiang Kang has succeeded Häcki in China. Kang worked as site manager in Singapore and has gained experience as a product manager in Germany in preparation for his new functions in China.

Internationally experienced executives
On behalf of the executive management, Friedbert Klefenz, president of Bosch Packaging Technology, thanked Wolfgang Szczerba for his commitment over the past decades. At the same time, he wished Walter Häcki, Uwe Harbauer and Chee Kiang Kang success in their new positions. “These appointments once again underline the long-term orientation of Bosch Packaging Technology. Both business units, as well as the entire division, will profit from long-term and international experience of their new managers,” said Klefenz.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bosch and Klenzaids Plan Joint Venture in India
Expansion of activities within pharmaceutical sector.
Thursday, December 04, 2014
Bosch Packaging Technology to Build Second Plant in China
Production in Chengdu to begin in early 2012 in leased production hall.
Tuesday, November 08, 2011
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!